Cost-effectiveness analysis in a setting of budget constraints--is it equitable?
- PMID: 8602185
- DOI: 10.1056/NEJM199605023341807
Cost-effectiveness analysis in a setting of budget constraints--is it equitable?
Abstract
Background: One of the promises of cost-effective analysis is that it can demonstrate how to maximize health benefits attainable within a specific limited budget. Many people argue, however, that when there are budget limitations, the use of cost-effectiveness analysis leads to health care policies that are inequitable.
Methods: We asked prospective jurors, medical ethicists, and experts in medical decision making to choose between two screening tests for a population at low risk for colon cancer. One test was more cost effective than the other but because of budget constraints was too expensive to be given to everyone in the population. With the use of the more effective test for only half the population, 1100 lives could be saved at the same cost as that of saving 1000 lives with the use of the less effective test for the entire population.
Results: Fifty-six percent of the prospective jurors, 53 percent of the medical ethicists, and 41 percent of the experts in medical decision making recommended offering the less effective screening test to everyone, even though 100 more lives would have been saved by offering the more expensive test to only a portion of the population. Most of the study participants justified this recommendation on the basis of equity. A smaller number stated either that it was not politically feasible to offer a test to only half the population or that the additional benefit of the more expensive test (100 more lives saved) was too small to justify offering it to only a portion of the public.
Conclusions: People place greater importance on equity than is reflected by cost-effectiveness analysis. Even many experts in medical decision making -- those often responsible for conducting cost-effectiveness analyses -- expressed discomfort with some of its implications. Basing health care priorities on cost effectiveness may not be possible without incorporating explicit considerations of equity into cost-effectiveness analyses or the process used to develop health care policies on the basis of such analyses.
Comment in
-
Cost-effectiveness analysis and budget constraints.N Engl J Med. 1996 Nov 7;335(19):1465; author reply 1466. doi: 10.1056/NEJM199611073351914. N Engl J Med. 1996. PMID: 8927085 No abstract available.
-
Cost-effectiveness analysis and budget constraints.N Engl J Med. 1996 Nov 7;335(19):1465; author reply 1466. N Engl J Med. 1996. PMID: 8927086 No abstract available.
-
Cost-effectiveness analysis and budget constraints.N Engl J Med. 1996 Nov 7;335(19):1465; author reply 1466. N Engl J Med. 1996. PMID: 8927087 No abstract available.
Similar articles
-
Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.Health Policy. 2005 Oct;74(2):146-56. doi: 10.1016/j.healthpol.2004.12.015. Epub 2005 Jan 26. Health Policy. 2005. PMID: 16153475
-
Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.Lung Cancer. 2005 May;48(2):171-85. doi: 10.1016/j.lungcan.2004.11.001. Epub 2005 Jan 4. Lung Cancer. 2005. PMID: 15829317
-
Cost-effectiveness analysis and budget constraints.N Engl J Med. 1996 Nov 7;335(19):1465; author reply 1466. doi: 10.1056/NEJM199611073351914. N Engl J Med. 1996. PMID: 8927085 No abstract available.
-
Screening of colorectal cancer.Surg Oncol Clin N Am. 2005 Oct;14(4):699-722. doi: 10.1016/j.soc.2005.05.009. Surg Oncol Clin N Am. 2005. PMID: 16226687 Review.
-
The use of cost-effectiveness by the National Institute for Health and Clinical Excellence (NICE): no(t yet an) exemplar of a deliberative process.J Med Ethics. 2008 Jul;34(7):534-9. doi: 10.1136/jme.2007.021683. J Med Ethics. 2008. PMID: 18591289 Review.
Cited by
-
The Devils in the DALY: Prevailing Evaluative Assumptions.Public Health Ethics. 2020 Oct 29;13(3):259-274. doi: 10.1093/phe/phaa030. eCollection 2020 Nov. Public Health Ethics. 2020. PMID: 33391391 Free PMC article.
-
The potential role of cost-utility analysis in the decision to implement major system change in acute stroke services in metropolitan areas in England.Health Res Policy Syst. 2018 Mar 14;16(1):23. doi: 10.1186/s12961-018-0301-5. Health Res Policy Syst. 2018. PMID: 29540216 Free PMC article.
-
Economic evaluation of infertility treatment for tubal disease.J Assist Reprod Genet. 2003 Aug;20(8):301-8. doi: 10.1023/a:1024853322988. J Assist Reprod Genet. 2003. PMID: 12948091 Free PMC article.
-
How many lives is equity worth? A proposal for equity adjusted years of life saved.J Epidemiol Community Health. 1998 Dec;52(12):808-11. doi: 10.1136/jech.52.12.808. J Epidemiol Community Health. 1998. PMID: 10396522 Free PMC article.
-
Societal views on orphan drugs: cross sectional survey of Norwegians aged 40 to 67.BMJ. 2010 Sep 22;341:c4715. doi: 10.1136/bmj.c4715. BMJ. 2010. PMID: 20861122 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources